Xponance Inc. Sells 988 Shares of Amedisys, Inc. (NASDAQ:AMED)

Xponance Inc. lessened its stake in Amedisys, Inc. (NASDAQ:AMED) by 19.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,152 shares of the health services provider’s stock after selling 988 shares during the period. Xponance Inc.’s holdings in Amedisys were worth $381,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Allianz Asset Management GmbH grew its position in Amedisys by 146.0% in the 4th quarter. Allianz Asset Management GmbH now owns 39,855 shares of the health services provider’s stock worth $3,789,000 after purchasing an additional 23,655 shares during the period. Water Island Capital LLC grew its position in Amedisys by 185.0% in the 4th quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after purchasing an additional 461,368 shares during the period. Nomura Holdings Inc. grew its position in Amedisys by 604.2% in the 4th quarter. Nomura Holdings Inc. now owns 49,297 shares of the health services provider’s stock worth $4,686,000 after purchasing an additional 42,297 shares during the period. SG Americas Securities LLC grew its position in Amedisys by 41.6% in the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock worth $3,517,000 after purchasing an additional 11,264 shares during the period. Finally, BNP Paribas Financial Markets grew its position in Amedisys by 111.7% in the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock worth $1,111,000 after purchasing an additional 6,358 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.7 %

AMED opened at $95.85 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95. The firm’s fifty day moving average is $97.55 and its 200 day moving average is $95.02. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of -149.77, a price-to-earnings-growth ratio of 1.90 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.10. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The company had revenue of $591.19 million for the quarter, compared to analysts’ expectations of $579.34 million. On average, sell-side analysts forecast that Amedisys, Inc. will post 4.66 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft downgraded shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price objective for the company. in a research report on Monday, July 29th. Finally, William Blair downgraded shares of Amedisys from an “outperform” rating to a “market perform” rating in a research report on Monday, July 1st. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $100.67.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.